Literature DB >> 18317462

Interacting haplotypes at the NPAS3 locus alter risk of schizophrenia and bipolar disorder.

B S Pickard1, A Christoforou, P A Thomson, A Fawkes, K L Evans, S W Morris, D J Porteous, D H Blackwood, W J Muir.   

Abstract

The neuronal PAS domain 3 (NPAS3) gene encodes a neuronal transcription factor that is implicated in psychiatric disorders by the identification of a human chromosomal translocation associated with schizophrenia and a mouse knockout model with behavioural and hippocampal neurogenesis defects. To determine its contribution to the risk of psychiatric illness in the general population, we genotyped 70 single-nucleotide polymorphisms across the NPAS3 gene in 368 individuals with bipolar disorder, 386 individuals with schizophrenia and 455 controls. Modestly significant single-marker and global and individual haplotypes were identified in four discrete regions of the gene. The presence of both risk and protective haplotypes at each of these four regions indicated locus and allelic heterogeneity within NPAS3 and suggested a model whereby interactions between variants across the gene might contribute to susceptibility to illness. This was supported by predicting the most likely haplotype for each individual at each associated region and then calculating an NPAS3-mediated 'net genetic load' value. This value differed significantly from controls for both bipolar disorder (P=0.0000010) and schizophrenia (P=0.0000012). Logistic regression analysis also confirmed the combinatorial action of the four associated regions on disease risk. In addition, sensitivity/specificity plots showed that the extremes of the genetic loading distribution possess the greatest predictive power-a feature suggesting multiplicative allele interaction. These data add to recent evidence that the combinatorial analysis of a number of relatively small effect size haplotypes may have significant power to predict an individual's risk of a complex genetic disorder such as psychiatric illness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317462     DOI: 10.1038/mp.2008.24

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  42 in total

Review 1.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

2.  Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems.

Authors:  L Cinnamon Bidwell; Jane Metrik; John McGeary; Rohan H C Palmer; S Francazio; Valerie S Knopik
Journal:  J Stud Alcohol Drugs       Date:  2013-11       Impact factor: 2.582

3.  A mutation in NPAS3 segregates with mental illness in a small family.

Authors:  L Yu; N Arbez; L G Nucifora; G L Sell; L E Delisi; C A Ross; R L Margolis; F C Nucifora
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992

Review 4.  Chromosome abnormalities, mental retardation and the search for genes in bipolar disorder and schizophrenia.

Authors:  D H R Blackwood; T Thiagarajah; P Malloy; B S Pickard; W J Muir
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

5.  A fast-evolving human NPAS3 enhancer gained reporter expression in the developing forebrain of transgenic mice.

Authors:  Gretel B Kamm; Rodrigo López-Leal; Juan R Lorenzo; Lucía F Franchini
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-11-11       Impact factor: 6.237

6.  The interaction between coagulation factor 2 receptor and interleukin 6 haplotypes increases the risk of myocardial infarction in men.

Authors:  Bruna Gigante; Anna M Bennet; Karin Leander; Max Vikström; Ulf de Faire
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

7.  A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression.

Authors:  Helen M Knight; Benjamin S Pickard; Alan Maclean; Mary P Malloy; Dinesh C Soares; Allan F McRae; Alison Condie; Angela White; William Hawkins; Kevin McGhee; Margaret van Beck; Donald J MacIntyre; John M Starr; Ian J Deary; Peter M Visscher; David J Porteous; Ronald E Cannon; David St Clair; Walter J Muir; Douglas H R Blackwood
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

Review 8.  The genetics of bipolar disorder.

Authors:  J H Barnett; J W Smoller
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

9.  Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.

Authors:  Masashi Ikeda; Yuko Okahisa; Branko Aleksic; Mujun Won; Naoki Kondo; Nobuya Naruse; Kumi Aoyama-Uehara; Ichiro Sora; Masaomi Iyo; Ryota Hashimoto; Yoshiya Kawamura; Nao Nishida; Taku Miyagawa; Masatoshi Takeda; Tsukasa Sasaki; Katsushi Tokunaga; Norio Ozaki; Hiroshi Ujike; Nakao Iwata
Journal:  Neuropsychopharmacology       Date:  2013-04-12       Impact factor: 7.853

10.  High-resolution chromosome ideogram representation of recognized genes for bipolar disorder.

Authors:  Lindsay N Douglas; Austen B McGuire; Ann M Manzardo; Merlin G Butler
Journal:  Gene       Date:  2016-04-07       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.